R-Mini-CHOP Versus R-Bendamustine As Primary Treatment for Diffuse Large B-Cell Lymphoma (DLBCL) in Elderly and Comorbid Patients

被引：5
|
作者：
Hammersen, Jakob [1 ]
Ruethrich, Maria Madeleine [2 ]
Kleber, Martina [3 ]
Wedding, Ulrich [2 ]
Sommer, Michael [4 ]
Mueller, Daniela [2 ]
Schlattmann, Peter [2 ]
Hochhaus, Andreas [2 ]
La Rosee, Paul [2 ]
机构：
[1] Univ Hosp, Jena, Germany
[2] Univ Hosp Jena, Jena, Germany
[3] Univ Basel Hosp, CH-4031 Basel, Switzerland
[4] Universityhosp Jena, Jena, Germany
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
10.1182/blood.V124.21.5436.5436
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Patient, caregiver, and physician preferences for treatment of relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL).
    Vukcevic, Mirko
    Yung, Mallory
    Khan, Maliha
    Schnell, Frederick Mark
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18710 - E18710
  • [42] Primary Cutaneous Diffuse Large B-cell Lymphoma Successfully Treated With R-CHOP Chemotherapy
    Alghamdi, Wafa M.
    Aljehani, Fawaz H.
    Alharthi, Abdullah M.
    Bakhsh, Reda I.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [43] R-CHOP14 compared to R-CHOP21 in elderly patients with diffuse large B-cell lymphoma (DLBCL): Final analysis of the LNH03-6B GELA study.
    Delarue, Richard
    Tilly, Herve
    Salles, Gilles A.
    Thieblemont, Catherine
    Mounier, Nicolas
    Molina, Thierry Jo
    Haioun, Corinne
    Bosly, Andre
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [44] Inpatient treatment of relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL): A health economic perspective
    Moertl, Bernhard
    Dreyling, Martin
    Schmidtl, Christian
    Hoster, Eva
    Schoel, Wolfgang
    V. Bergwelt-Baildon, Michael
    Berger, Karin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (07): : 474 - 482
  • [45] Impact of primary prophylaxis by pegfilgrastim in diffuse large B-cell lymphoma treated with R-CHOP
    Moonho Kim
    Yongchel Ahn
    Heui-June Ahn
    Suk-Hun Ha
    Ho-Suk Oh
    Jae-Seok Song
    Woong-Sub Park
    Sang-Wook Yi
    Annals of Hematology, 2023, 102 : 3167 - 3175
  • [46] Impact of primary prophylaxis by pegfilgrastim in diffuse large B-cell lymphoma treated with R-CHOP
    Kim, Moonho
    Ahn, Yongchel
    Ahn, Heui-June
    Ha, Suk-Hun
    Oh, Ho-Suk
    Song, Jae-Seok
    Park, Woong-Sub
    Yi, Sang-Wook
    ANNALS OF HEMATOLOGY, 2023, 102 (11) : 3167 - 3175
  • [47] Effect of atorvastatin versus placebo on efficacy in patients with diffuse large B-cell lymphoma receiving R-CHOP
    Nemec, Ronald
    Scherrer-Crosbie, Marielle
    Abramson, Jeremy S.
    Redd, Robert
    Gilman, Hannah K.
    Ho, Terry
    Wu, Jessica
    Heemelaar, Julius
    Neuberg, Donna
    Hochberg, Ephraim P.
    Barnes, Jeffrey A.
    Armand, Philippe
    Jacobsen, Eric D.
    Jacobson, Caron A.
    Kim, Austin I.
    Friedman, Robb S.
    LaCasce, Ann S.
    Neilan, Tomas G.
    Soumerai, Jacob D.
    LEUKEMIA & LYMPHOMA, 2024, 65 (06) : 783 - 788
  • [48] Total Cost of Care in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
    Gatwood, Justin
    Masaquel, Anthony
    Ross, Ryan
    Sheinson, Danny
    Hossain, Farah
    Li, Jia
    James, Cameron
    Fox, David
    BLOOD, 2022, 140 : 7906 - 7907
  • [49] SERUM B2-MICROGLOBULIN LEVELS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): PROGNOSTIC SIGNIFICANCE UNDER TREATMENT WITH RITUXIMAB-CHOP (R-CHOP)
    Vassilakopoulos, T. P.
    Anastasopoulou, A.
    Constantinou, N.
    Angelopoulou, M. K.
    Stavroulaki, E.
    Kalpadakis, C.
    Sachanas, S.
    Pappis, V.
    Tsirkinidis, P.
    Moschoyiannis, M.
    Tsopra, O.
    Tzenou, T.
    Gassiamis, A.
    Yiakoumis, X.
    Kyrtsonis, M. C.
    Kokoris, S. I.
    Siakantaris, M. P.
    Dimou, M.
    Georgiou, G.
    Plata, E.
    Viniou, N. A.
    Variamis, E.
    Konstantopoulos, K.
    Panayiotidis, P.
    Papadaki, H.
    Pangalis, G. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 393 - 394
  • [50] Rituximab, bevacizumab (avastin) and CHOP (RA-CHOP) for patients with diffuse large B-cell lymphoma (DLBCL).
    Ganjoo, KN
    Gordon, L
    Robertson, MJ
    Horning, SJ
    BLOOD, 2004, 104 (11) : 389A - 389A
12345